EntryPoint Capital’s Genelux GNLX Stock Holding History

EntryPoint Capital’s Portfolio GNLX Stock Details GNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16,380	Closed	-$229K	–	1551
2023 Q4	$229K	Buy	+16,380	New	+$259K	0.22%	61

Other funds holding GNLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WDC

Woodward Diversified Capital Bakersfield, California $220M AUM 30.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PWM

Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EntryPoint Capital's GNLX Position: Q1 2024 in Review

EntryPoint Capital sold out of Genelux (GNLX) in Q1 2024, closing a stake of 16,380 shares — an estimated $229K sold.

EntryPoint Capital first reported a position in GNLX in Q4 2023 and held it in 1 quarter. The position peaked at $229K in Q4 2023. 67 funds tracked by Wall St. Rank hold GNLX as of Q1 2024.

EntryPoint Capital reported no remaining Genelux position as of Q1 2024 after selling out during the quarter.
EntryPoint Capital sold 16,380 Genelux shares in Q1 2024, an estimated $229K.
EntryPoint Capital first reported a position in Genelux in Q4 2023 and held it in 1 quarter.
EntryPoint Capital's Genelux position peaked at $229K in Q4 2023.
67 funds tracked by Wall St. Rank held Genelux as of Q1 2024.

Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.